Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses.
about
Lysergic acid diethylamide: a drug of 'use'?Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsThe effect of psilocin on memory acquisition, retrieval, and consolidation in the ratPilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addictionClinical applications of hallucinogens: A review.The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.Therapeutic Applications of Classic Hallucinogens.The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging.Psychedelics in the treatment of unipolar mood disorders: a systematic review.An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives.Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision.A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment.Research on psychedelic substances.Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance use.N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and FunctionPredicting Responses to Psychedelics: A Prospective Study
P2860
Q26746133-71867F2A-D9F5-4A1A-AFB7-D2CBD3F4F8E9Q26746137-288300A9-E095-4043-87E2-79086EAD73D9Q33658155-AF6B083D-CDAF-443F-9C06-66AE1807C60DQ34438146-16DA991C-3DAB-4057-9FAD-CE39BAD46E41Q34535259-DF69D307-3014-470A-B4A3-FA25252E3C35Q34546304-10732A41-6A44-4583-8FDF-04B20D0F3401Q35126018-D9C46952-872F-44DB-9148-B620D3015E4BQ37052393-63ECFE79-384D-4186-92FE-482A1253167AQ38781678-A3F6221F-1B32-4F0C-B312-44F443E241D3Q38861685-DC331D5D-8C80-49B3-AED1-58D8DFDA55FCQ39011321-0A90F7B1-2F8E-428F-A9F7-955FAE38F162Q39016513-EAF94C48-E032-4884-9267-FFBE1D93E9BEQ39237019-B9637419-D75E-41FF-98E7-8152037B6070Q39834312-4F5FAA06-FB34-4736-80E5-B7EA1E18A3D7Q41586201-D4094629-387F-4802-AB55-EECC02BC67E5Q44539047-05F7A484-2949-4C06-AA09-89770ED7A239Q46847604-473CCDC7-2BA7-4CF7-803E-317BCBE23043Q48420021-3B350E02-ED23-4F3D-9AB6-5F4C19829697Q55059681-46267A4D-EEA7-4F97-B8AC-425290918A0DQ57075471-259E91B9-644E-47C3-A51A-9FF7F78AF3B8Q59137436-55CE567C-92F2-43E5-8F5E-624F6BD94928
P2860
Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutic mechanisms of clas ...... idence to testable hypotheses.
@en
type
label
Therapeutic mechanisms of clas ...... idence to testable hypotheses.
@en
prefLabel
Therapeutic mechanisms of clas ...... idence to testable hypotheses.
@en
P2860
P356
P1476
Therapeutic mechanisms of clas ...... idence to testable hypotheses.
@en
P2093
Jessica M Pommy
P2860
P304
P356
10.1002/DTA.1376
P577
2012-07-04T00:00:00Z